Lp(a) in Pediatrics

Author(s):

Key Takeaways

Pediatric lipid screening is vital for early dyslipidemia detection, reducing future cardiovascular disease risk.
Guidelines suggest universal screening at ages 9-11 and 17-21, with selective screening for at-risk children.
Implementation is inconsistent due to barriers like lack of awareness and time constraints in clinical settings.
Strategies to enhance uptake include routine integration, electronic health record reminders, and education for providers and families.

Panelists discuss how early identification of lipid disorders through pediatric screening is crucial yet underutilized, highlighting current guidelines and practical strategies to improve screening implementation in clinical practice.

EP: 1.Prevalence of Cardiovascular Disease

EP: 2.AHA Guidelines and Patient Mortality

EP: 3.Role of LDL-C in ASCVD

EP: 4.Pediatric Lipid Screening

Now Viewing

EP: 5.Lp(a) in Pediatrics

EP: 6.DCRM Recommendations for Lipid Testing and LDL-C Management

Video content above is prompted by the following:

Can you describe the importance of pediatric lipid screening? What are the current recommendations and are they being implemented?
Are there practical strategies you could recommend to improve the uptake of pediatric lipid screening?